Cargando…

Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery

PURPOSE: Currently, the prognostic value of molecular subtypes in ductal carcinoma in situ (DCIS) remains unclear. In this study, we explored whether molecular subtypes could predict second breast events (SBEs) in patients after breast‐conserving surgery (BCS). METHODS: From January 2008 to December...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yilan, Zhao, Xu, Wang, Xuanyi, Jin, Kairui, Luo, Jurui, Yang, Zhaozhi, Mei, Xin, Ma, Jinli, Shao, Zhimin, Zhang, Zhen, Chen, Xingxing, Guo, Xiaomao, Yu, Xiaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302274/ https://www.ncbi.nlm.nih.gov/pubmed/35598318 http://dx.doi.org/10.1002/cam4.4651

Ejemplares similares

Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients
por: Wang, Jiangfeng, et al.
Publicado: (2020)

Outcomes in Patients with pT3N0M0 Breast Cancer with and without Postmastectomy Radiotherapy
por: Li, Chunyan, et al.
Publicado: (2021)

Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion
por: Li, Chunyan, et al.
Publicado: (2021)

Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
por: Wang, Xiaofang, et al.
Publicado: (2021)

Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy
por: Chen, Xingxing, et al.
Publicado: (2018)

CDK4/6 inhibitors: a novel strategy for tumor radiosensitization
por: Yang, Yilan, et al.
Publicado: (2020)

Outcomes Following Salvage Radiation and Systemic Therapy for Isolated Locoregional Recurrence of Breast Cancer after Mastectomy: Impact of Constructed Biologic Subtype
por: Wang, Xiaofang, et al.
Publicado: (2018)

The Value of (18)F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
por: Luo, Jurui, et al.
Publicado: (2016)

Clinicopathological Characteristics of Breast Ductal Carcinoma In Situ: An Analysis of Chinese Population of 617 Patients
por: Mao, Guangmin, et al.
Publicado: (2021)

Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells
por: Chen, Xingxing, et al.
Publicado: (2017)

Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment
por: Wang, Xuanyi, et al.
Publicado: (2022)

Isolated locoregional recurrence patterns of breast cancer after mastectomy and adjuvant systemic therapies in the contemporary era
por: Ma, Jinli, et al.
Publicado: (2015)

Multibeam inverse intensity-modulated radiotherapy (IMRT) for whole breast irradiation: a single center experience in China
por: Yang, Zhaozhi, et al.
Publicado: (2015)

The Role of Radiotherapy for Patients with Unresectable Locally Advanced Breast Cancer following Neoadjuvant Systemic Therapy
por: Wang, Xiaofang, et al.
Publicado: (2023)

Intraoperative Radiotherapy Versus Whole-Breast External Beam Radiotherapy in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Li, et al.
Publicado: (2015)

Prognostic value of metabolic signature on 18F-FDGuptake in breast cancer patients after radiotherapy
por: Meng, Jin, et al.
Publicado: (2021)

Targeting deubiquitinase USP28 for cancer therapy
por: Wang, Xiaofang, et al.
Publicado: (2018)

HER2 reduces breast cancer radiosensitivity by activating focal adhesion kinase in vitro and in vivo
por: Hou, Jing, et al.
Publicado: (2016)

Ductal Carcinoma In Situ of the Breast: Perspectives on Tumor Subtype and Treatment
por: Liu, Yufei, et al.
Publicado: (2020)

Favorable prognosis of breast cancer brain metastases patients with limited intracranial and extracranial metastatic lesions
por: Shi, Wei, et al.
Publicado: (2023)

Molecular subtyping reveals uniqueness of prognosis in breast ductal carcinoma in situ patients with lumpectomy
por: Yang, Libo, et al.
Publicado: (2022)

Evaluation of automated breast volume scanner for breast conservation surgery in ductal carcinoma in situ
por: Huang, Anqian, et al.
Publicado: (2016)

Predictors of Recurrent Ductal Carcinoma In Situ after Breast-Conserving Surgery
por: Kim, Jung Yeon, et al.
Publicado: (2016)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

Does the protocol-required uniform margin around the CTV adequately account for setup inaccuracies in whole breast irradiation?
por: Luo, Jurui, et al.
Publicado: (2021)

Radiotherapy after Conservative Surgery in Ductal Carcinoma In Situ of the Breast: A Review
por: Amichetti, Maurizio, et al.
Publicado: (2012)

Impact of consensus guidelines for breast‐conserving surgery in patients with ductal carcinoma in situ
por: Tremelling, Abigail, et al.
Publicado: (2021)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Intensity modulated radiotherapy with fixed collimator jaws for locoregional left-sided breast cancer irradiation
por: Wang, Juanqi, et al.
Publicado: (2017)

The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype
por: Wei, Jinli, et al.
Publicado: (2020)

Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ
por: Farolfi, Alberto, et al.
Publicado: (2020)

Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?
por: Kim, Taeryung, et al.
Publicado: (2014)

Subtypes of high-grade breast ductal carcinoma in situ (DCIS): incidence and potential clinical impact
por: Schandiz, Hossein, et al.
Publicado: (2023)

The Feasibility of Omitting Postoperative Radiotherapy in Japanese Patients With Ductal Carcinoma In Situ of Breast Treated With Breast-Conserving Surgery
por: Nakashima, Akihiro, et al.
Publicado: (2023)

Trends and clinicopathological predictors of axillary evaluation in ductal carcinoma in situ patients treated with breast‐conserving therapy
por: Huang, Nai‐si, et al.
Publicado: (2017)

Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer
por: Choi, Young Jin, et al.
Publicado: (2016)

Single institution experience of split course radiotherapy in patients with desmoid tumors
por: Luo, Jurui, et al.
Publicado: (2019)

Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation
por: Wang, Kang, et al.
Publicado: (2021)

Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study
por: Vidali, Cristiana, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5db5qbledf47geguk2tqavo0nd